NR ASJA
AU Darbord,J.C.; Hauw,J.J.
TI [Hospital practice and prion risks]
OT Pratiques hospitalieres et risque Prion
QU Pathologie Biologie 2005 May; 53(4): 237-43
PT journal article; review
AB Procedures applicable in France for the prevention of prion diseases were first implemented in 1995, resulting from the threat of an epidemic extension of Creutzfeldt-Jakob Disease (CJD) following contamination resulting from the use of extracted growth hormone. It was found later that the bovine disease could infect humans via foodstuffs, and the human variant of the disease (v-CJD) transmissible through lymphoid formations was described in 1996. This led to generalizing precautions to a larger number of medical interventions, taking into account the risk for a population more broadly exposed to contamination. The principles for managing these new risks are described, as well for the use of medical devices or in patient as pathology laboratories.
ZR 16
MH Animals; Autopsy; Cattle; *Containment of Biohazards/methods/standards; Cross Infection/epidemiology/*prevention & control/transmission; Decontamination/methods/standards; Disinfection/methods/standards; Encephalopathy, Bovine Spongiform/transmission; Endoscopes; English Abstract; Equipment Contamination/prevention & control; Equipment Reuse; Equipment and Supplies, Hospital; Guidelines; Humans; Medical Waste Disposal/methods/standards; *Organizational Policy; Prion Diseases/epidemiology/*prevention & control/transmission; *Prions/analysis; Risk
AD Laboratoire des controles biologiques, pharmacie centrale des hopitaux, universite Paris-V, France. darbord@pharmacie.univ-paris5.fr
SP französisch
PO Frankreich